Age, Biography and Wiki

John F. Kerin was born on 8 August, 1944, is a doctor. Discover John F. Kerin's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 62 years old?

Popular As N/A
Occupation N/A
Age 62 years old
Zodiac Sign Leo
Born 8 August, 1944
Birthday 8 August
Birthplace N/A
Date of death 25 January 2006
Died Place N/A
Nationality

We recommend you to check the complete list of Famous People born on 8 August. He is a member of famous doctor with the age 62 years old group.

John F. Kerin Height, Weight & Measurements

At 62 years old, John F. Kerin height not available right now. We will update John F. Kerin's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

John F. Kerin Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is John F. Kerin worth at the age of 62 years old? John F. Kerin’s income source is mostly from being a successful doctor. He is from . We have estimated John F. Kerin's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income doctor

John F. Kerin Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1979

Kerin spent 16 years directing in vitro fertilisation units with the University of Adelaide (1979–1986), University of California, Los Angeles School of Medicine and Cedars-Sinai Medical Centre (1986–1991) and Fresenius Medical Care (1992–1995). While at Queen Elizabeth Hospital in Adelaide, South Australia, his team produced South Australia's first IVF twins. For 7 years he was a principal investigator for conducting international multi-centre Food and Drug Administration regulated clinical trials for assessing the safety and efficacy of reproductive technology. In June 2004 he was appointed the medical director of Flinders Reproductive Medicine.

1977

Kerin’s Ph.D. thesis was titled “On the endocrine function of the human GraaFian follicle”, submitted in December 1977 to the Department of Obstetrics and Gynaecology at the Queen Elizabeth Hospital, The University of Adelaide, in fulfilment of the requirements for the degree of Doctor of Medicine in which his aim was to obtain an “understanding of the changing cyclical relationship which exists between the theca and granulosa cells of the isolated human Graafian follicle, in vitro, with respect to its ability to produce the three basic classes of sex steroids, namely the androgens, oestrogens and progestins” and to “critically examine factors controlling human ovarian follicle behaviour, in the hope of achieving a better understanding of female ovarian function”.

1976

He was a member and fellow of the Royal College of Obstetricians and Gynaecologists since 1976 and 1971, respectively, and a foundation fellow (since 1979) of the Australian College of Obstetricians and Gynaecologists since 1979. Also, a FRCOG (England) 1986, and FACOG (AM) 1988.

1969

Born to Frank and Joan Mary Kerin, Kerin qualified with a Bachelor of Medicine and Surgery (MBBS) at the University of Adelaide in 1969. He was a fellow of the Royal Australasian College of Obstetrics and Gynecology (FRANZCOG) and had been awarded a Certificate in Reproductive Endocrinology and Infertility.

1944

John F. Kerin (8 August 1944 – 25 January 2006) was a physician, Professor of reproductive medicine, and was a recognised innovator in biomedical technology.